Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents

被引:321
作者
Citron, Diane M.
Goldstein, Ellie J. C.
Merriam, C. Vreni
Lipsky, Benjamin A.
Abramson, Murray A.
机构
[1] RM Alden Res Lab, Santa Monica, CA 90404 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
[3] Univ Washington, Sch Med, Seattle, WA USA
[4] VA Puget Sound Hlth Care Syst, Seattle, WA USA
[5] Merck & Co Inc, Merck Res Labs, West Point, PA USA
关键词
D O I
10.1128/JCM.00551-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
As part of a United States-based multicenter clinical trial, conducted from 2001 to 2004, that compared ertapenern to piperacillin-tazobactam for the treatment of moderate-to-severe diabetic foot infections (DFIs), we obtained 454 pretreatment specimens from 433 patients. After debridement, the investigators collected wound specimens, mostly by curettage or biopsy, and sent them to the R. M. Alden Research Laboratory for aerobic and anaerobic culture. Among the 427 positive cultures, 83.8% were polymicrobial, 48% grew only aerobes, 43.7% had both aerobes and anaerobes, and 1.3% had only anaerobes. Cultures yielded a total of 1,145 aerobic strains and 462 anaerobic strains, with an average of 2.7 organisms per culture (range, I to 8) for aerobes and 2.3 organisms per culture (range, I to 9) for anaerobes. The predominant aerobic organisms were oxacillin-susceptible Staphylococcus aureus (14.3%), oxacillin-resistant Staphylococcus aureus (4.4%), coagulase-negative Staphylococcus species (15.3%), Streptococcus species (15.5%), Enterococcus species (13.5%), Corynebacterium species (10.1%), members of the family Enterobacteriaceae (12.8%), and Pseudonumas aeruginosa (3.5%). The predominant anaerobes were gram-positive cocci (45.2%), Prevotella species (13.6%), Porphyromonas species (11.3%), and the Bacteroides fragilis group (10.2%). Pure cultures were noted for 20% of oxacillin-resistant Staphylococcus aureus cultures, 9.2% of Staphylococcus epidermidis cultures, and 2.5% of P. aeruginosa cultures. Two or more species of Staphylococcus were present in 13.1% of the patients. Ertapenem and piperacillin-tazobactam were each active against > 98% of the enteric gram-negative rods, methicillin-sensitive S. aureus, and anaerobes. Among the fluoroquinolones, 24% of anaerobes, especially the gram-positive cocci, were resistant to moxifloxacin; 27% of the gram-positive aerobes but only 6% of the members of the family Enterobacteriaceae were resistant to levofloxacin. Moderate-to-severe DFIs are typically polymicrobial, and almost half include anaerobes. Our antibiotic susceptibility results can help to inform therapeutic choices.
引用
收藏
页码:2819 / 2828
页数:10
相关论文
共 56 条
[1]   Bacteriological study of diabetic foot infections [J].
Abdulrazak, A ;
Bitar, ZI ;
Al-Shamali, AA ;
Mobasher, LA .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2005, 19 (03) :138-141
[2]  
[Anonymous], 2016, M45 CLSI
[3]   PREVALENCE OF MIXED INFECTIONS IN THE DIABETIC PEDAL WOUND - A RETROSPECTIVE REVIEW OF 112 INFECTIONS [J].
ARMSTRONG, DG ;
LISWOOD, PJ ;
TODD, WF .
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 1995, 85 (10) :533-537
[4]  
ASFAR SK, 1993, CAN J SURG, V36, P170
[5]   PREVALENCE OF CORYNEBACTERIA IN DIABETIC FOOT INFECTIONS [J].
BESSMAN, AN ;
GEIGER, PJ ;
CANAWATI, H .
DIABETES CARE, 1992, 15 (11) :1531-1533
[6]   The microbiology of infected and noninfected leg ulcers [J].
Bowler, PG ;
Davies, BJ .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1999, 38 (08) :573-578
[7]   Wound microbiology and associated approaches to wound management [J].
Bowler, PG ;
Duerden, BI ;
Armstrong, DG .
CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (02) :244-+
[8]  
Candel Gonzalez F J., 2003, Eur J Intern Med, V14, P341
[9]   Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene [J].
Chang, S ;
Sievert, DM ;
Hageman, JC ;
Boulton, ML ;
Tenover, FC ;
Downes, FP ;
Shah, S ;
Rudrik, JT ;
Pupp, GR ;
Brown, WJ ;
Cardo, D ;
Fridkin, SK .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1342-1347
[10]  
*CLIN LAB STAND I, 2004, M11A6 CLSI